The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-70
SponsorFudan University
About this trial
The breast cancer patients who received radiotherapy after mastectomy and breast reconstruction will be enrolled. The skin microbiome before radiotherapy and its changes after radiotherapy will be analyzed systematically to find out whether the skin microbiome is associated with the severity of radiation dermatitis.
Eligibility criteria
Qualifiers
Female patients
Invasive breast cancer confirmed by pathology
Underwent mastectomy and breast reconstruction
Radiotherapy after breast reconstruction
Disqualifiers
Previous breast or chest radiotherapy
Other serious skin diseases (systemic lupus erythematosus, skin sclerosis, et al) and cannot receive radiotherapy
Pregnant women
Patients who are unwilling or unable to receive regular follow-up.
Trial design
Treatments tested in this trial
- post-operative radiotherapy
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov